/** * FHIR Version R5 * The following is auto generated resource definition. * * OpenAPI spec version: 3.0.1 * * * NOTE: This class is auto generated by the swagger code generator program. * https://github.com/swagger-api/swagger-codegen.git * Do not edit the class manually. */ import { Code } from './code'; import { CodeableConcept } from './codeableConcept'; import { CodeableReference } from './codeableReference'; import { Coding } from './coding'; import { DateTime } from './dateTime'; import { Extension } from './extension'; import { Id } from './id'; import { Identifier } from './identifier'; import { Markdown } from './markdown'; import { MarketingStatus } from './marketingStatus'; import { MedicinalProductDefinitionCharacteristic } from './medicinalProductDefinitionCharacteristic'; import { MedicinalProductDefinitionContact } from './medicinalProductDefinitionContact'; import { MedicinalProductDefinitionCrossReference } from './medicinalProductDefinitionCrossReference'; import { MedicinalProductDefinitionName } from './medicinalProductDefinitionName'; import { MedicinalProductDefinitionOperation } from './medicinalProductDefinitionOperation'; import { Meta } from './meta'; import { Narrative } from './narrative'; import { Reference } from './reference'; import { ResourceList } from './resourceList'; import { Uri } from './uri'; /** * A medicinal product, being a substance or combination of substances that is intended to treat, prevent or diagnose a disease, or to restore, correct or modify physiological functions by exerting a pharmacological, immunological or metabolic action. This resource is intended to define and detail such products and their properties, for uses other than direct patient care (e.g. regulatory use, or drug catalogs). */ export interface MedicinalProductDefinition { /** * This is a MedicinalProductDefinition resource */ resourceType: 'MedicinalProductDefinition'; id?: Id; meta?: Meta; implicitRules?: Uri; language?: Code; text?: Narrative; /** * These resources do not have an independent existence apart from the resource that contains them - they cannot be identified independently, nor can they have their own independent transaction scope. This is allowed to be a Parameters resource if and only if it is referenced by a resource that provides context/meaning. */ contained?: Array; /** * May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. */ extension?: Array; /** * May be used to represent additional information that is not part of the basic definition of the resource and that modifies the understanding of the element that contains it and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and managable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer is allowed to define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). */ modifierExtension?: Array; /** * Business identifier for this product. Could be an MPID. When in development or being regulated, products are typically referenced by official identifiers, assigned by a manufacturer or regulator, and unique to a product (which, when compared to a product instance being prescribed, is actually a product type). See also MedicinalProductDefinition.code. */ identifier?: Array; type?: CodeableConcept; domain?: CodeableConcept; version?: string; status?: CodeableConcept; statusDate?: Date; description?: Markdown; combinedPharmaceuticalDoseForm?: CodeableConcept; /** * The path by which the product is taken into or makes contact with the body. In some regions this is referred to as the licenced or approved route. See also AdministrableProductDefinition resource. MedicinalProductDefinition.route is the same concept as AdministrableProductDefinition.routeOfAdministration.code, and they cannot be used together. */ route?: Array; indication?: Markdown; legalStatusOfSupply?: CodeableConcept; additionalMonitoringIndicator?: CodeableConcept; /** * Whether the Medicinal Product is subject to special measures for regulatory reasons, such as a requirement to conduct post-authorization studies. */ specialMeasures?: Array; pediatricUseIndicator?: CodeableConcept; /** * Allows the product to be classified by various systems, commonly WHO ATC. */ classification?: Array; /** * Marketing status of the medicinal product, in contrast to marketing authorization. This refers to the product being actually 'on the market' as opposed to being allowed to be on the market (which is an authorization). */ marketingStatus?: Array; /** * Package type for the product. See also the PackagedProductDefinition resource. */ packagedMedicinalProduct?: Array; /** * Types of medicinal manufactured items and/or devices that this product consists of, such as tablets, capsule, or syringes. Used as a direct link when the item's packaging is not being recorded (see also PackagedProductDefinition.package.containedItem.item). */ comprisedOf?: Array; /** * The ingredients of this medicinal product - when not detailed in other resources. This is only needed if the ingredients are not specified by incoming references from the Ingredient resource, or indirectly via incoming AdministrableProductDefinition, PackagedProductDefinition or ManufacturedItemDefinition references. In cases where those levels of detail are not used, the ingredients may be specified directly here as codes. */ ingredient?: Array; /** * Any component of the drug product which is not the chemical entity defined as the drug substance, or an excipient in the drug product. This includes process-related impurities and contaminants, product-related impurities including degradation products. */ impurity?: Array; /** * Additional information or supporting documentation about the medicinal product. */ attachedDocument?: Array; /** * A master file for the medicinal product (e.g. Pharmacovigilance System Master File). Drug master files (DMFs) are documents submitted to regulatory agencies to provide confidential detailed information about facilities, processes or articles used in the manufacturing, processing, packaging and storing of drug products. */ masterFile?: Array; /** * A product specific contact, person (in a role), or an organization. */ contact?: Array; /** * Clinical trials or studies that this product is involved in. */ clinicalTrial?: Array; /** * A code that this product is known by, usually within some formal terminology, perhaps assigned by a third party (i.e. not the manufacturer or regulator). Products (types of medications) tend to be known by identifiers during development and within regulatory process. However when they are prescribed they tend to be identified by codes. The same product may be have multiple codes, applied to it by multiple organizations. */ code?: Array; /** * The product's name, including full name and possibly coded parts. */ name: Array; /** * Reference to another product, e.g. for linking authorised to investigational product, or a virtual product. */ crossReference?: Array; /** * A manufacturing or administrative process or step associated with (or performed on) the medicinal product. */ operation?: Array; /** * Allows the key product features to be recorded, such as \"sugar free\", \"modified release\", \"parallel import\". */ characteristic?: Array; }